Home » Newsletters » BioWorld Science

BioWorld Science

May 10, 2001

View Archived Issues

Parke-Davis (Pfizer) isothiazolone inhibits early phase of HIV replication

Pharming reports results for Q1 2001

New dietary supplement improves hair growth

New option for patients with refractory B-CLL will be available soon in U.S.

Plans to codevelop ACAT inhibitor for atherosclerosis announced by Lilly, bioMerieux-Pierre Fabre

Pharmacia's Zyvoxam approved in Canada for Gram-positive bacterial infections

Soltara moves into formal review at the FDA

Promising preclinical data reported for argatroban in rat ischemic stroke model

Schering-Plough seeks approval in Japan for Rebetol/Intron combination for hepatitis C

Efficacy and safety of new glutamate receptor antagonist evaluated during a migraine attack

AstraZeneca completes patient enrollment in NSCLC phase III trials of Iressa

ImmunoGen's lead product enters third phase I/II trial

AAN news: proteasome inhibitor PS-519 reduces functional impairment following ICH

Oral heparin completes phase I testing

Dexanabinol exerts long-term neuroprotective effects in stroke, as reported at AAN meeting

Infigen and Immerge BioTherapeutics collaborate on xenotransplantation research

Biopure's Hemopure blood substitute proves highly effective in pivotal trial

Gentamicin tested in patients with muscular dystrophy and stop codon mutations

Vertex licenses Deltagen technology for drug discovery based on gene function

PhotoCure reports update on company progress during the first quarter

Patented series from BMS particularly useful for type 2 diabetes

Etoposide and paclitaxel conjugates prepared by Nobex for improving drug delivery

New vitamin D3 derivatives and their use described by Chugai

Cysteine protease inhibitors undergo research at Kissei

Wakunaga presents novel antibacterial agents devoid of phototoxicity

Preparation, binding and use of novel NMDA antagonists disclosed by Roche

New treatments for gallstones in development at Aventis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...